Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
Find the perfect cards to make your season’s greetings go even further. Every pack purchased will help fund vital research and support for people living with type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > Knowledge & support > Resource hub > The ELSA study enables early detection of type 1 diabetes
Cerilyn found out her daughter, five-year-old Alys, has begun developing type 1 diabetes by taking part in the ELSA study, a Breakthrough T1D UK-funded research project screening children in the UK.
We decided to sign Alys and her sister Emily up for the ELSA study because their dad and grandad both live with type 1. We thought ‘it’s only a finger prick’, so we just tried – we weren’t really expecting either of the girls to test positive. Detecting type 1 diabetes early was the main reason we decided to take part. The benefits of early detection include lower lifetime HbA1c levels, and a reduced risk of diabetic ketoacidosis (DKA) and long-term diabetes complications.
Shortly after signing up, we received the test kit in the post. All we had to do was a simple finger prick test and put blood spots on the card provided. The finger prick didn’t faze the girls at all – neither Alys nor Emily even remembers doing it!
Then, just two weeks later, a doctor from the ELSA team called us and told us that Emily didn’t have any signs of type 1, but Alys had tested positive for proteins called autoantibodies, which show that she is developing the condition. That call floored us. At first, I felt devastated for Alys, but then I thought that the ELSA study has given her the best possible start to type 1.
The team gave us free travel from our home in Swansea to Cardiff hospital for Alys to have a further blood test to show which autoantibodies she has. It was quite nerve-wracking waiting for these results as it took a bit longer than the first stage.
A couple of months later, Alys had an oral glucose tolerance test, which the ELSA team let us do in the school holidays so that Alys didn’t have to miss any more school. The test involved not eating for eight hours, then doing a blood test, followed by drinking a very sweet-tasting drink.
To allow the doctor to take blood at regular intervals, Alys had a small tube called a cannula put in her arm. She didn’t like the cannula at all because the process was made more challenging by her blood clotting around the cannula. But the short-term discomfort and stress this caused her is far better than the lasting consequences of an emergency diagnosis of type 1 in DKA.
The ELSA study team is phenomenal. Especially Dr Lauren Quinn, who answered all our queries, ran an education session with us and a closing interview where we could feed back on the study. The team also offered us support from a psychologist, but I didn’t feel like we needed it as we are coping well.
We are now under the care of a consultant at a local diabetes clinic and can still call the ELSA study team if we need anything. They gave us a Dexcom ONE continuous glucose monitor (CGM) to use every six weeks to monitor Alys’s blood sugar levels. She likes the CGM as she can wear stickers over it!
I really recommend taking part in the ELSA study. For people with a genetic link to type 1, it’s important because having a family history of the condition increases your own risk. For those without family members living with type 1, it’s not something that’s in your world until it happens. So, the education aspect is crucial to learn the signs and symptoms of type 1 diabetes and help prevent a diagnosis in DKA. The long-term benefits far outweigh the short-term stress of going through screening. It’s well worth it! If you’re concerned about taking part, speak to the ELSA study team. They’re very reassuring and will walk you through each step.
Having advanced warning that Alys will develop type 1 diabetes has given us precious time to prepare for managing the condition. The challenges we had with the cannula during the OGTT have made Alys nervous about needing insulin injections. I saw other parents online using TickleF LEX to help their young children cope with injections, so we bought one to help Alys. We’ve all been practicing carb-counting and both girls have been getting involved in their dad’s diabetes management by reading out his glucose levels and helping with his injections. Alys is very into science, so she’s been learning all about how her body works and reading Super Sammy! (A Tale For Type 1 Superheroes).
A few months after testing positive in the ELSA study, Alys’ blood sugar levels were increasing. She was having hypers every night, which made her very thirsty, and falling asleep in school, showing how tired she was. We knew that type 1 was approaching. So, we called our local diabetes consultant and began insulin treatment in a calm, controlled way in the comfort of our home – rather than in a stressful hospital environment – on World Diabetes Day 2023.
Learn more about the ELSA study.
Discover how we are screening people for type 1 diabetes.
Donate to Breakthrough T1D UK now to help fund research like this.
Gabby’s son took part in the ELSA study, which looks for the early signs of type 1 diabetes (T1D) before symptoms develop. Gabby spoke to us about how knowing early is helping them prepare for life with T1D.
Justine Steventon is navigating menopause while living with type 1 diabetes. Her hybrid closed loop (HCL) system and hormone replacement therapy (HRT) are helping restore her energy, confidence, and sense of control.
Older adults with type 1 diabetes (T1D) are often left out of conversations about technology. Below, Diabetes Specialist Nurse Katie Hards explains why hybrid closed loop systems could be life-changing for people with complex care needs.
Retired accountant Andy Buckle has lived with type 1 diabetes for almost five decades. After a demanding career, he began to think about how he could contribute something meaningful.
Our research is improving the lives of people with type 1 and making strides towards a cure. We’ll keep pushing until we make type 1 diabetes a thing of the past.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?
